Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ark Genomic Revolution ETF (ARKG)

Ark Genomic Revolution ETF (ARKG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Ark Funds
  • Assets Under Management 1,098,367,000
  • Shares Outstanding, K 42,050
  • 60-Month Beta 1.50
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 0.382 on 12/29/21
  • Management Fee 0.75%
  • INDUSTRY GROUPING:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 37.35% ( -1.33%)
  • Historical Volatility 34.02%
  • IV Percentile 2%
  • IV Rank 9.90%
  • IV High 86.12% on 04/08/25
  • IV Low 31.99% on 12/24/24
  • Put/Call Vol Ratio 0.70
  • Today's Volume 5,181
  • Volume Avg (30-Day) 6,523
  • Put/Call OI Ratio 0.28
  • Today's Open Interest 327,041
  • Open Int (30-Day) 319,894

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.92 +10.22%
on 06/13/25
26.47 -4.54%
on 07/10/25
+0.99 (+4.10%)
since 06/11/25
3-Month
20.21 +25.01%
on 04/21/25
26.47 -4.54%
on 07/10/25
+4.23 (+20.14%)
since 04/11/25
52-Week
17.50 +44.33%
on 04/07/25
31.16 -18.92%
on 02/18/25
+0.43 (+1.75%)
since 07/11/24

Most Recent Stories

More News
Cathie Wood Loves This Under-the-Radar AI Stock. Is It Time for You to Buy Now?

The popular investor poured $366.2 million in the company’s shares to carry out her latest purchase.

ARKG : 25.27 (-3.29%)
SFTBY : 35.7200 (-2.59%)
TEM : 56.88 (-4.56%)
ARKK : 72.29 (-1.73%)
Best-Performing ETFs of Last Week

Wall Street was upbeat last week, with the S&P 500 adding 1.5%, the Dow Jones gaining about 0.6% and the Nasdaq surging 2.6%. Last week witnessed the release of hot January inflation data. The Consumer...

ODDS : 30.99 (-0.74%)
ABNY : 11.72 (-0.92%)
ARKG : 25.27 (-3.29%)
MS : 142.28 (-0.57%)
KWEB : 33.86 (-0.59%)
UNG : 14.92 (+1.15%)
Tempus AI Stock Swings Wildly As Earnings Near, Retail’s Cautiously Optimistic After Insider Sales

The company has gained a lot of attention since launching an AI-enabled personal health app last month.

ARKG : 25.27 (-3.29%)
IBB : 131.59 (-1.54%)
VTI : 307.02 (-0.42%)
TEM : 56.88 (-4.56%)
Cathie Wood Just Doubled Down on This AI Stock. Should You?

The stock is one of the renowned investor’s top holdings.

ARKG : 25.27 (-3.29%)
MRK : 83.36 (-0.79%)
TEM : 56.88 (-4.56%)
ARKK : 72.29 (-1.73%)
TAK : 14.68 (-1.08%)
BNTX : 112.89 (-0.90%)
Intellia Stock Dips After Morgan Stanley Downgrade, Retail Sentiment Weakens

The brokerage pointed to the company’s recent discontinuation of its NTLA-3001 program for alpha-1 antitrypsin deficiency-associated lung disease, reducing near-term growth prospects.

ARKG : 25.27 (-3.29%)
IBB : 131.59 (-1.54%)
XBI : 87.02 (-1.54%)
NTLA : 11.53 (-5.14%)
Tempus AI Stock Eyes Best Rally In 5 Months Amid Pelosi-Linked Hype, But Retail’s Turning Doubtful Now

A regulatory filing from Wednesday night disclosed that Tempus AI founder and CEO Eric Lefkofsky sold 946,084 shares of Tempus between Jan. 15-17.

ARKG : 25.27 (-3.29%)
IBBQ : 22.01 (-1.61%)
TEM : 56.88 (-4.56%)
ARKK : 72.29 (-1.73%)
Here Are the 6 Largest Stock Holdings in All of Cathie Wood's ETFs Right Now

Asset management company Ark Invest offers nine different investment funds, eight of which are available as exchange-traded funds, or ETFs. They all have a different tech-related focus, such as robotics,...

ARKX : 24.97 (+1.22%)
ARKF : 51.00 (-1.11%)
ARKW : 149.33 (-0.97%)
ARKG : 25.27 (-3.29%)
ARKQ : 91.86 (+1.18%)
ARKK : 72.29 (-1.73%)
Options Alert: Should Investors Jump on This Cathie Wood-Owned Life Sciences Specialist?

While proteomics firms Quantum-Si has made waves recently, QSI stock might not be the long-term play value investors are seeking.

ARKG : 25.27 (-3.29%)
QSI : 1.7300 (-4.42%)
1 AI Stock Cathie Wood Is Buying Instead of Tesla

Cathie Wood is shifting away from Tesla, zeroing in on an AI-driven healthcare firm that is revolutionizing precision medicine and advanced diagnostics.

TSLA : 313.51 (+1.17%)
ARKG : 25.27 (-3.29%)
TEM : 56.88 (-4.56%)
UTHR : 295.52 (-1.55%)
ARKK : 72.29 (-1.73%)
BNTX : 112.89 (-0.90%)
Best-Performing ETF Areas of Last Week

The Dow Jones Industrial Average and the S&P 500 climbed to new record levels on Friday, closing out a strong month for equities. The Dow Jones rose 1.4% last week, while the S&P 500 and the Nasdaq...

ARKX : 24.97 (+1.22%)
TSLA : 313.51 (+1.17%)
ARKG : 25.27 (-3.29%)
GNOM : 8.85 (-1.88%)
ETH : 28.37 (+6.73%)
HDRO : 25.92 (-0.12%)
XRT : 80.26 (-0.84%)
HYDR : 24.40 (-2.75%)
ETHV : 44.17 (+6.90%)
UFO : 29.73 (-1.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Fund Summary

The ARK Genomic Revolution ETF seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology, materials,...

See More

Key Turning Points

3rd Resistance Point 26.48
2nd Resistance Point 26.19
1st Resistance Point 25.73
Last Price 25.27
1st Support Level 24.98
2nd Support Level 24.69
3rd Support Level 24.23

See More

52-Week High 31.16
Fibonacci 61.8% 25.94
Last Price 25.27
Fibonacci 50% 24.33
Fibonacci 38.2% 22.72
52-Week Low 17.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar